Enzastaurin


Indications and Reactions:

Role Indications Reactions
Secondary
Diffuse Large B-cell Lymphoma 51.4%
Drug Use For Unknown Indication 28.1%
Non-small Cell Lung Cancer 4.4%
Prostate Cancer Metastatic 2.9%
Prostate Cancer 2.1%
Glioma 1.5%
Prophylaxis 1.4%
B-cell Lymphoma 1.2%
Hypertension 1.1%
Stomatitis 1.1%
Diffuse Large B-cell Lymphoma Recurrent 1.0%
Colon Cancer Metastatic 0.8%
Genital Neoplasm Malignant Female 0.5%
Hyperlipidaemia 0.5%
Glioblastoma 0.4%
Glioblastoma Multiforme 0.4%
Bile Duct Cancer 0.3%
Colon Cancer 0.3%
Hypothyroidism 0.3%
Supplementation Therapy 0.3%
Weight Decreased 12.3%
Hypotension 7.3%
Neutropenia 7.3%
Tachycardia 6.7%
Vomiting 6.7%
Sepsis 6.1%
Pneumonia 5.6%
Pneumocystis Jiroveci Pneumonia 5.0%
Septic Shock 5.0%
Ventricular Tachycardia 5.0%
Supraventricular Tachycardia 4.5%
Femoral Neck Fracture 3.9%
Pain 3.4%
Pulmonary Embolism 3.4%
Thrombocytopenia 3.4%
Thrombosis 3.4%
Urinary Tract Infection 3.4%
Acute Respiratory Distress Syndrome 2.8%
Neutropenic Sepsis 2.8%
Arrhythmia 2.2%
Concomitant
Drug Use For Unknown Indication 60.0%
B-cell Lymphoma 24.0%
Glioma 8.0%
Peritoneal Carcinoma 4.0%
Pain In Extremity 2.0%
Pain Management 2.0%
Platelet Count Decreased 28.6%
Xerosis 28.6%
Aspiration 14.3%
Pneumonia Aspiration 14.3%
Prothrombin Level Increased 14.3%

Drug Data